Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19

Interim immunogenicity and efficacy data for the Ad26.COV2.S vaccine for COVID-19 have recently been reported(1–3). We describe here the 8-month durability of humoral and cellular immune responses in 20 individuals who received one or two doses of 5×10(10) vp or 10(11) vp Ad26.COV2.S and in 5 partic...

Full description

Saved in:
Bibliographic Details
Published in:medRxiv
Main Authors: Barouch, Dan H., Stephenson, Kathryn E., Sadoff, Jerald, Yu, Jingyou, Chang, Aiquan, Gebre, Makda, McMahan, Katherine, Liu, Jinyan, Chandrashekar, Abishek, Patel, Shivani, Le Gars, Mathieu, de Groot, Anne Marit, Heerwegh, Dirk, Struyf, Frank, Douoguih, Macaya, van Hoof, Johan, Schuitemaker, Hanneke
Format: Artigo
Language:Inglês
Published: Cold Spring Harbor Laboratory 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8282116/
https://ncbi.nlm.nih.gov/pubmed/34268527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.07.05.21259918
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items